Lhasa Limited shared knowledge shared progress
Publications
  • Highlighted Item:
  • Webinar:
  • Publisher:
    Regulatory Toxicology and Pharmacology
  • Publication Date:
    AUG 2022
  • Reference:
  • DOI:
    10.1016/j.yrtph.2022.105248
  • PMID:
  • Publication Type:
    Paper
  • Related Products:
  • Scientific Area:
  • Endpoint:
    Skin
  • Industry Type:
  • Related event:

How to resolve inconclusive predictions from defined approaches for skin sensitisation in OECD Guideline No. 497

Macmillan DS; Chilton ML; Gao Y; Kern P; Schneider SN;

In June 2021, the OECD published Guideline No. 497 on Defined Approaches for Skin Sensitisation. There are two defined approaches published, known as the 2o3 and the ITS. The 2o3 uses two concordant results from either the DPRA, KeratinoSens™, or the h-CLAT assays to predict hazard (sensitiser/non-sensitiser). The ITS applies a score to results from the DPRA, the h-CLAT and an in silico model to predict United Nations Globally Harmonized System (GHS) sub-categories (1A/1B/Not Classified). The ITS can use Derek Nexus as the in silico model (known as v1) or use OECD QSAR Toolbox (known as v2).

In this paper, co-author and Principal Scientist, Martyn Chilton discusses how to resolve inconclusive predictions from defined approaches for skin sensitisation in OECD Guideline No. 497.

Access the paper via the button below!

Visit site

© 2023 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).